Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Colorectal Neoplasms

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Colorectal Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bandaru, VVR; Chatterjee, SB; Hou, J; Pezhouh, MK; Sharma, R; Syed Rifat Mannan, AA	1
Gu, X; Hill, RA; Hosain, SB; Ingram, C; Khiste, SK; Liu, YY; Uddin, MB; Vorubindi, V; Zhang, S	1

Other Studies

2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Colorectal Neoplasms

Article	Year
Lactosylceramide synthase β-1,4-GalT-V: A novel target for the diagnosis and therapy of human colorectal cancer. Biochemical and biophysical research communications, 2019, 01-08, Volume: 508, Issue:2 Topics: Biomarkers, Tumor; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Enzyme Inhibitors; Galactosyltransferases; HCT116 Cells; Humans; Immunohistochemistry; Lactosylceramides; Morpholines; Signal Transduction; Sphingolipids; Up-Regulation	2019
Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells. Oncotarget, 2016, Sep-13, Volume: 7, Issue:37 Topics: Animals; Carcinogenesis; Cell Dedifferentiation; Cell Line, Tumor; Colorectal Neoplasms; CRISPR-Cas Systems; Doxorubicin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Glucosyltransferases; Humans; Mice; Mice, Nude; Morpholines; Mutation, Missense; Neoplastic Stem Cells; RNA, Small Interfering; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2016

Article

Year

Lactosylceramide synthase β-1,4-GalT-V: A novel target for the diagnosis and therapy of human colorectal cancer.

Biochemical and biophysical research communications, 2019, 01-08, Volume: 508, Issue:2

Topics: Biomarkers, Tumor; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Enzyme Inhibitors; Galactosyltransferases; HCT116 Cells; Humans; Immunohistochemistry; Lactosylceramides; Morpholines; Signal Transduction; Sphingolipids; Up-Regulation

2019

Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.

Oncotarget, 2016, Sep-13, Volume: 7, Issue:37

Topics: Animals; Carcinogenesis; Cell Dedifferentiation; Cell Line, Tumor; Colorectal Neoplasms; CRISPR-Cas Systems; Doxorubicin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Glucosyltransferases; Humans; Mice; Mice, Nude; Morpholines; Mutation, Missense; Neoplastic Stem Cells; RNA, Small Interfering; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2016